Clinical Trial Update: Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns

View source ↗

Summary

A clinical trial evaluating trastuzumab deruxtecan for metastatic breast cancer with varying HER2 expression patterns is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Breast Cancer | Status: RECRUITING